Transvenous Mitral Valve Replacement After Failure of Surgical Ring Annuloplasty

Himbert, Dominique; Descoutures, Fleur; Brochet, Éric; Iung, Bernard; Détaint, Delphine; Messika–Zeitoun, David; Alkhoder, Soleiman; Mimoun, Léa; Sordi, Martina; Depoix, Jean‐Pol; Ducrocq, Grégory; Nataf, Patrick; Vahanian, Alec

doi:10.1016/j.jacc.2012.05.033

Cited by 21 publications

(7 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recently, THV implantation has also been reported for treatment of failed mitral BP or RA, mainly through the transapical approach (7)(8)(9)(10)(11)(12)(13)(14)(15). T H V i m p l a n t a t i o n p r o c e d u r e s. The technique for THV implantation in mitral position through a transfemoral approach has been described previously (8,16,17 a "J" curve at the end was placed in the apex of the left ventricle ( Figure 1A). The atrial septum was dilated using 12-to 14-mm peripheral balloons.…”

mentioning

confidence: 99%

Transfemoral Implantation of Transcatheter Heart Valves After Deterioration of Mitral Bioprosthesis or Previous Ring Annuloplasty

Bouleti

Fassa

Himbert

et al. 2015

JACC: Cardiovascular Interventions

Self Cite

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Transfemoral Implantation of Transcatheter Heart Valves After Deterioration of Mitral Bioprosthesis or Previous Ring Annuloplasty

Bouleti

Fassa

Himbert

et al. 2015

JACC: Cardiovascular Interventions

Self Cite

View full text Add to dashboard Cite

show abstract

“…Malapposition and noncircularity might lead to leaflet malcoaptation, resulting in regurgitation and early degeneration of the device. The overall experience of VIR is mostly limited to isolated clinical case reports, small series and animal studies [10,14,[22][23][24] . Descoutures et al [10] reported preliminary multicenter results of 17 cases, and that VIR may provide short-term clinical and hemodynamic improvement.…”

Section: Discussionmentioning

confidence: 99%

“…Despite being an antegrade access to the mitral valve, due to the long wires and catheters, device positioning and delivery is less precise [11] . The other antegrade approach is the transatrial access that offers distinct advantages for mitral implants, namely (1) the ease of antegrade valve crossing, (2) atrial access with eased bleeding control, (3) a more linear and coaxial angle to the mitral valve [24] and (4) a short working distance with easier stabilization for device deployment [10] . Our study confirms the eased mitral valve crossing using the transatrial rather than the transapical access [13] .…”

Section: Discussionmentioning

confidence: 99%

New Self-Expanding Transcatheter Valve for Off-Pump Transatrial Mitral Valve-In-Ring Implantation

Yu¹,

Huber²,

Li³

et al. 2015

Cardiology

View full text Add to dashboard Cite

and moderate regurgitation in 1. Mean gradients were 6.1 ± 5.0 mm Hg across the device. Postmortem examination confirmed adequate positioning of devices within the annuloplasty ring. Conclusions: This custom-made transcatheter device allows for safe and reproducible off-pump transatrial mitral VIR implantations. Transatrial access is a promising route to facilitate VIR implantations. Our custom-made stent-valve may be suitable for VIR procedures.

show abstract

“…However, in exceptional circumstances, circular mitral annular calcification is severe enough to cause hemodynamically significant mitral stenosis and may offer enough support to allow stable anchoring of a percutaneous mitral prosthesis 95, 96 .…”

Section: Treatmentmentioning

confidence: 99%

Pathophysiology and management of multivalvular disease

et al. 2016

View full text Add to dashboard Cite

Multivalvular disease (MVD) is a common condition with a complex pathophysiology, dependent on the specific combination of valve lesions. Diagnosis is challenging as several echocardiographic methods commonly used for the assessment of stenosis or regurgitation have been validated only in patients with single valve disease. Decisions about the timing and type of treatment should be made by a multidisciplinary heart valve team, on a case-by-case basis. Several factors should be considered, including the severity and consequences of the MVD, the patient’s life expectancy and comorbidities, the surgical risk associated with combined valve procedures, the long-term risk of morbidity and mortality associated with multiple valve prostheses, and the likelihood and risk of reoperation. The introduction of transcatheter valve therapies into clinical practice has provided new treatment options for patients with MVD, and decision-making algorithms on how to combine surgical and percutaneous treatment options are evolving rapidly. In this Review, we discuss the pathophysiology, diagnosis, and treatment of MVD, focussing on the combination of valve pathologies that are most often encountered in clinical practice.

show abstract

Transvenous Mitral Valve Replacement After Failure of Surgical Ring Annuloplasty

Cited by 21 publications

References 6 publications

Transfemoral Implantation of Transcatheter Heart Valves After Deterioration of Mitral Bioprosthesis or Previous Ring Annuloplasty

Transfemoral Implantation of Transcatheter Heart Valves After Deterioration of Mitral Bioprosthesis or Previous Ring Annuloplasty

New Self-Expanding Transcatheter Valve for Off-Pump Transatrial Mitral Valve-In-Ring Implantation

Pathophysiology and management of multivalvular disease

Contact Info

Product

Resources

About